Ivermectin vs Merck’s New Early Treatment Drug
Newsmax’s Host Eric Bolling interviews Dr. Pierre Kory about Ivermectin and Merck’s new drug.
Donate to the Front Line Covid-19 Critical Care Alliance, Inc
To educate medical professionals and the public in safe and effective ways to prevent and treat COVID-19.
Original Source: https://www.australiannationalreview.com/state-of-affairs/ivermectin-vs-mercks-new-early-treatment-drug/
